<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">URO</journal-id>
<journal-id journal-id-type="hwp">spuro</journal-id>
<journal-title>Journal of Clinical Urology</journal-title>
<issn pub-type="ppub">2051-4158</issn>
<issn pub-type="epub">2051-4166</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/2051415813480498</article-id>
<article-id pub-id-type="publisher-id">10.1177_2051415813480498</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A very unusual metastatic pattern exhibited by a mixed non-seminomatous germ cell tumour: a case report and review of literature</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Osman</surname><given-names>Elsawi</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Gomha</surname><given-names>Mohamed</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Aldayel</surname><given-names>Adel</given-names></name>
</contrib>
<aff id="aff1-2051415813480498">Urology Department, King Fahad Specialist Hospital, Saudi Arabia</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-2051415813480498">Elsawi Osman, Urology Department, King Fahad Specialist Hospital, Dammam, 15215 Saudi Arabia Email: <email>sawi11@hotmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2013</year>
</pub-date>
<volume>6</volume>
<issue>4</issue>
<fpage>263</fpage>
<lpage>265</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>12</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>20</day>
<month>1</month>
<year>2013</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>1</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>© British Association of Urological Surgeons 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">British Association of Urological Surgeons</copyright-holder>
</permissions>
<abstract>
<p>It is a known fact that the retroperitoneum is the commonest metastatic site for testicular germ cell tumours. Contrary to this we are hereby reporting a case of an advanced testicular non-seminomatous germ cell tumour (NSGCT) presenting with a huge anterior abdominal wall metastatic mass and no evidence of retroperitoneal lymphadenopathy. A 36 year-old gentleman who underwent bilateral orchidopexies as a child, presented with a huge anterior abdominal wall mass engulfing the external genitalia. Incisional biopsy showed a yolk sac tumour. He was treated primarily with immediate chemotherapy with a dramatically good response. This was followed by right radical orchidectomy. Unfortunately, a few months later he developed recurrences into the anterior abdominal wall as well as brain metastasis. We conclude with two main messages. Firstly, previous inguino-scrotal procedures can significantly alter the lymphatic drainage from the testicles. Secondly, primary chemotherapy before orchidectomy can have a very favourable outcome in selected patients.</p>
</abstract>
<kwd-group>
<kwd>Germ cell metastasis</kwd>
<kwd>subcutaneous metastasis</kwd>
<kwd>subcutaneous mass metastasis</kwd>
<kwd>non-seminomatous germ cell tumour metastasis</kwd>
<kwd>abdominal wall metastatic masses</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-2051415813480498" sec-type="intro">
<title>Introduction</title>
<p>With the exception of choriocarcinoma, which has a propensity to haematogenous spread, retroperitoneal lymph nodes are the primary metastatic site for testicular germ cell tumours. We report a case of a very unusual metastatic pattern from a mixed non-seminomatous germ cell tumour (NSGCT), presenting as a huge subcutaneous anterior abdominal mass and sparing the retroperitoneum.</p>
</sec>
<sec id="section2-2051415813480498" sec-type="cases">
<title>Case Report</title>
<p>A 36 year-old gentleman presented with a huge fungating lower anterior abdominal wall mass with areas of black discolouration and offensive odour. The mass was progressively increasing in size over the preceding 18 months. He was completely bed bound for a few weeks due to the size of the mass. As a relevant past medical history, our patient underwent left open orchidopexy, followed by right open orchidopexy at the ages of 9 and 11 years respectively. He had secondary infertility for the last nine years. Physical examination, showed a generally cachectic patient. Locally, there was a giant mass measuring around 40 cm × 45 cm involving the lower anterior abdominal wall and suprapubic areas. Moreover the external genitalia were engulfed within the mass that had islands of necrosis. Within the right testicle there was a non-tender firm mass, while the left hemiscrotum could not be felt distinctly. The penis was globally swollen and indurated with areas of nodularity all over the shaft with a Foley catheter in situ. Testicular tumour markers, showed stage 2 (S2) elevation. Scrotal ultrasound scan (U/S) showed a right testicular heterogeneous mass with some cystic areas. Left testicle could not be clearly visualized. Chest X-ray (CXR) showed multiple metastatic nodules (cannon balls).</p>
<p>Incisional biopsy of the fungating mass (<xref ref-type="fig" rid="fig1-2051415813480498">Figure 1</xref>) showed a yolk sac tumour which was strongly positive to Alpha Feto Protein (AFP) immunostain. Staging computed tomography (CT) of the chest, abdomen and pelvis (<xref ref-type="fig" rid="fig2-2051415813480498">Figure 2</xref>) revealed a giant subcutaneous lower abdominal mass, with no significant retroperitoneal lymph node metastasis, and widespread areas of metastasis including lungs, spleen, right kidney, right gluteal region subcutaneous nodule and right quadriceps femoris muscle metastasis.</p>
<fig id="fig1-2051415813480498" position="float">
<label>Figure 1.</label>
<caption>
<p>The fungating mass during incisional biopsy procedure.</p>
</caption>
<graphic xlink:href="10.1177_2051415813480498-fig1.tif"/>
</fig>
<fig id="fig2-2051415813480498" position="float">
<label>Figure 2.</label>
<caption>
<p>Axial views showing the subcutaneous location of the mass with no involvement of the retroperitoneum.</p>
</caption>
<graphic xlink:href="10.1177_2051415813480498-fig2.tif"/>
</fig>
<p>Being poor prognosis stage III NSGCT, the patient received four cycles of cisplatin, etoposide and bleomycin (PEB) as an initial measure without significant complications. Post chemotherapy, the patient had a clinically fantastic response with complete melt down of &gt;95% of the abdominal mass (<xref ref-type="fig" rid="fig3-2051415813480498">Figure 3</xref>).</p>
<fig id="fig3-2051415813480498" position="float">
<label>Figure 3.</label>
<caption>
<p>Axial view of computed tomography (CT) scan showing the excellent response to chemotherapy.</p>
</caption>
<graphic xlink:href="10.1177_2051415813480498-fig3.tif"/>
</fig>
<p>Consequently, the left testicle was found to be located in the left hemi-scrotal neck. It was of normal size and consistency and became completely separable from the abdominal mass. Immediately post chemotherapy, the patient underwent right radical orchidectomy with excision of a mid-shaft penile ventral nodule. Interestingly, the histopathology of the testicle showed no active malignancy with the presence of cartilage, denoting teratomatous elements. There was weak positivity to AFP on immune-histochemistry. Histopathological examination of the penile nodule, showed only histocytic reaction. Clinically there was a small residual subcutaneous nodule around 2 cm in diameter in the lower anterior abdominal wall. This started to increase in size gradually, with a progressive rise in tumour markers necessitating the use of second and third line chemotherapy (paclitaxel, ifosfamide and cisplatin (TIP) and etoposide, ifosfamide and cisplatin (VIP) protocols) with some response. Lately, the patient developed brain metastasis and is awaiting palliative radiotherapy.</p>
</sec>
<sec id="section3-2051415813480498" sec-type="discussion">
<title>Discussion</title>
<p>Compared to seminoma, NSGCT tends to present at an earlier age and it is less common. Around 90% of all NSGCT cases are associated with elevated tumour markers, namely AFP for yolk sac elements and B-subunit of Human chorionic gonadotropin (BHCG) which is raised in all choriocarcinomas. NSGCT has a higher probability of relapse following radical orchidectomy alone when compared to seminoma (30% for NSGCT and 15–20% for seminoma).</p>
<p>The standard treatment of NSGCT following radical orchidectomy depends on the clinical stage and can further be guided by histological and clinical prognostic criteria listed in <xref ref-type="table" rid="table1-2051415813480498">Table 1</xref>. Chemotherapy using PEB regimen is the first line adjuvant treatment. Active surveillance can be adopted in well selected patients with good prognostic factors who are well informed, motivated and compliant.<sup><xref ref-type="bibr" rid="bibr1-2051415813480498">1</xref></sup> Retroperitoneal lymph node dissection (RPLND) becomes indicated in cases with recurrent or residual post chemotherapy masses.</p>
<table-wrap id="table1-2051415813480498" position="float">
<label>Table 1.</label>
<caption>
<p>Poor prognostic criteria for non-seminomatous germ cell tumour (NSGCT).</p>
</caption>
<graphic alternate-form-of="table1-2051415813480498" xlink:href="10.1177_2051415813480498-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Histological</th>
<th align="left">Clinical</th>
</tr>
</thead>
<tbody>
<tr>
<td>Embryonal carcinoma &gt;50%</td>
<td>Mediastinal primary</td>
</tr>
<tr>
<td>Lymphatic/vascular or peri-tumoural invasion</td>
<td>Non-pulmonary visceral metastasis</td>
</tr>
<tr>
<td>Proliferation rate &gt;70%</td>
<td>AFP &gt;10,000 ng/ml<break/>HCG &gt; 50,000 IU/l<break/>LDH &gt; 10× upper limit of normal</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-2051415813480498"><p>AFP: Alpha Feto Protein; HCG: Human chorionic gonadotropin; LDH: Lactate Dehydrogenase.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In the light of the aforementioned case scenario, the mass was very likely to be representing a huge subcutaneous secondaries from a right testicular primary. A second possibility could be giant fungating inguinal lymph nodes, given the previous history of orchidopexy which could have interrupted with the normal lymph drainage.Furthermore, the presence of right upper thigh muscle metastasis could be contributing to the inguinal lymph node metastasis.</p>
<p>In the English literature, there are only two previously reported cases resembling this mode of presentation. One case reported by Ghosh et al.<sup><xref ref-type="bibr" rid="bibr4-2051415813480498">4</xref></sup> was a proven fungating retroperitoneal lymph node. While the second case from Zangana et al.<sup><xref ref-type="bibr" rid="bibr5-2051415813480498">5</xref></sup> reported a pure teratoma with a smaller mass size. There are few reports of subcutaneous metastasis from germ cell tumours in general, with some authors suggesting that subcutaneous tissue could be the primary<sup><xref ref-type="bibr" rid="bibr6-2051415813480498">6</xref><xref ref-type="bibr" rid="bibr7-2051415813480498"/>–<xref ref-type="bibr" rid="bibr8-2051415813480498">8</xref></sup> origin of these germ cell tumours.<sup><xref ref-type="bibr" rid="bibr9-2051415813480498">9</xref><xref ref-type="bibr" rid="bibr10-2051415813480498"/>–<xref ref-type="bibr" rid="bibr11-2051415813480498">11</xref></sup> In addition to reporting this unusual presentation, we also stress upon two other observations. Firstly the possible disruption of the normal testicular lymphatic drainage system by previous surgical procedures, and secondly the encouraging response to chemotherapy as a primary treatment in well selected patients.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Conflicts of interest</label>
<p>The authors declare that there are no conflicts of interest.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-2051415813480498">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Albers</surname><given-names>P</given-names></name><etal/>
</person-group>. <source>Euro Urol</source> <year>2008</year>; <volume>53</volume>: <fpage>478</fpage>–<lpage>496</lpage>, <fpage>497</fpage>–<lpage>513</lpage>.</citation>
</ref>
<ref id="bibr2-2051415813480498">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Del Peso</surname><given-names>AC</given-names></name><etal/>
</person-group>. <source>Arch Esp Urol</source> <year>2009</year>; <volume>62</volume>: <fpage>389</fpage>–<lpage>392</lpage>.</citation>
</ref>
<ref id="bibr3-2051415813480498">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hamid</surname><given-names>AR</given-names></name>
<name><surname>Umbas</surname><given-names>R</given-names></name>
</person-group> <source>Acta Med Indones</source> <year>2009</year>; <volume>41</volume>: <fpage>25</fpage>–<lpage>29</lpage>.</citation>
</ref>
<ref id="bibr4-2051415813480498">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ghosh</surname><given-names>I</given-names></name>
<name><surname>Raina</surname><given-names>V</given-names></name>
</person-group> <source>Indian J Urol</source> <year>2011</year>; <volume>27</volume>: <fpage>280</fpage>–<lpage>281</lpage>.</citation>
</ref>
<ref id="bibr5-2051415813480498">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zangana</surname><given-names>AM</given-names></name>
<name><surname>Razak</surname><given-names>AB</given-names></name>
</person-group> <source>Saudi Med J</source> <year>2007</year>; <volume>28</volume>: <fpage>465</fpage>–<lpage>467</lpage>.</citation>
</ref>
<ref id="bibr6-2051415813480498">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tinkle</surname><given-names>LL</given-names></name>
<name><surname>Graham</surname><given-names>BS</given-names></name>
<name><surname>Spillane</surname><given-names>TJ</given-names></name><etal/>
</person-group>. <source>Cutis</source>. <year>2001</year>; <volume>67</volume>: <issue>2</issue>: <fpage>117</fpage>–<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr7-2051415813480498">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shimizu</surname><given-names>S</given-names></name>
<name><surname>Nagata</surname><given-names>Y</given-names></name>
<name><surname>Han-yaku</surname><given-names>H.</given-names></name>
</person-group> <source>Am J Dermatopathol</source> <year>1996</year>; <volume>18</volume>: <fpage>633</fpage>–<lpage>636</lpage>.</citation>
</ref>
<ref id="bibr8-2051415813480498">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ahmadi</surname><given-names>SA</given-names></name>
<name><surname>Tavakoli</surname><given-names>H</given-names></name>
<name><surname>Samadi</surname><given-names>N</given-names></name>
</person-group> <source>Eur Arch Otorhinolaryngol</source> <year>2006</year>; <volume>263</volume>: <fpage>290</fpage>–<lpage>292</lpage>.</citation>
</ref>
<ref id="bibr9-2051415813480498">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Winter</surname><given-names>CC</given-names></name>
<name><surname>Trepashko</surname><given-names>DW</given-names></name>
</person-group> <source>Urology</source> <year>1989</year>; <volume>33</volume>: <fpage>320</fpage>–<lpage>321</lpage>.</citation>
</ref>
<ref id="bibr10-2051415813480498">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>X</given-names></name>
<name><surname>Xu</surname><given-names>L</given-names></name>
<name><surname>Chen</surname><given-names>X</given-names></name><etal/>
</person-group>. <source>J Cutan Pathol</source> <year>2010</year>; <volume>37</volume>: <fpage>486</fpage>–<lpage>290</lpage>.</citation>
</ref>
<ref id="bibr11-2051415813480498">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gleizal</surname><given-names>A</given-names></name>
<name><surname>Torossian</surname><given-names>JM</given-names></name>
<name><surname>Wan</surname><given-names>DC</given-names></name><etal/>
</person-group>. <source>Br J Oral Maxillofac Surg</source> <year>2008</year>; <volume>46</volume>: <fpage>416</fpage>–<lpage>418</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>